pharma
AstraZeneca to pit blood cancer drug Calquence against COVID-19 with the company’s fastest-ever trial launch
April 14, 2020Manufacturing and Production, Research and Development AstraZeneca, COVID-19, Calquence, coronavirus, pharma
As the R&D race against COVID-19 continues, AstraZeneca is poised to launch a global, multicentre clinical trial to test its …
Gilead’s promising COVID-19 drug remdesivir shows benefit in 68% of hospitalised patients
April 14, 2020Manufacturing and Production, Research and Development COVID-19, Gilead, coronavirus, pharma, remdesivir
Gilead has provided an update on its ongoing efforts against the novel coronavirus, revealing data from a cohort analysis of …
Circassia terminates AstraZeneca partnership in exchange for £150m debt settlement
April 9, 2020Sales and Marketing AstraZeneca, Circassia, partnership, pharma, respiratory
Circassia Pharmaceuticals has announced its decision to break away from a partnership it forged with AstraZeneca UK back in 2017 …
Roche signs multi-billion dollar RNA-targeted drug discovery deal with Arrakis Therapeutics
April 9, 2020Research and Development, Sales and Marketing Arrakis, Roche, partnership, pharma
Roche has signed a new partnership with Arrakis Therapeutics in a bid to drive discovery of RNA-targeted small molecule (rSM) …
Envision Pharma Group acquires healthcare comms consultancy 90TEN
April 9, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 90TEN, Envision Pharma Group, pharma
Global healthcare communications consultancy 90TEN has been acquired by Envision Pharma Group, it has been revealed. 90TEN said that it …
Sage Therapeutics to halve its total workforce in radical cost-cutting move
April 8, 2020Research and Development, Sales and Marketing Sage Therapeutics, pharma, staff cuts
Sage Therapeutics has revealed a radical restructuring effort to cut costs and “enable the company to advance its corporate strategy …
Second Genome to help drive development of Gilead therapies in potential $1.5bn deal
April 8, 2020Research and Development Gilead, Second Genome, pharma
Gilead and microbiome science specialist Second Genome have announced they are to partner up to advance a selection of the …
Takeda’s Alunbrig outclasses Xalkori to secure EU approval in ALK+ advanced non-small cell lung cancer
April 7, 2020Manufacturing and Production, Sales and Marketing Alunbrig, Europe, Takeda, pharma
The European Commission has ruled to expand the current approved indication of Takeda’s Alunbrig (brigatinib), authorising the drug as a …
FDA approval for BMS and Acceleron’s Reblozyl to reduce red blood cell transfusion dependence
April 6, 2020Manufacturing and Production, Sales and Marketing BMS, FDA, Reblozyl, pharma
The FDA has given the regulatory thumbs-up in the US of Reblozyl (luspatercept-aamt), the “first and only erythroid maturation agent” …
European approval for Novo’s Rybelsus to control blood sugar in type 2 diabetes
April 6, 2020Sales and Marketing Novo Nordisk, Rybelsus, diabetes, pharma
The European Commission has greenlighted Novo Nordisk’s Rybelsus (oral semaglutide) as an adjunct to diet and exercise to improve glycaemic …
Industry veteran Dr David Setboun joins BrainStorm as Executive VP and COO
April 3, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BrainStorm Therapeutics, appointments, pharma
BrainStorm Cell Therapeutics, a firm developing cellular therapies to tackle neurodegenerative diseases, has named industry Big Pharma veteran Dr David …
Steven T Gill returns to Alimera as VP, Thought Leader Engagement
April 3, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alimera Sciences, Novartis, pharma
Ophthalmology specialist Alimera Sciences has announced that Steven T Gill is to return to the company in the newly created …
MSD’s Keytruda hits Phase 3 main goal in first-line colorectal cancer sub-population
April 3, 2020Medical Communications, Research and Development MSD, colorectal cancer, keytruda, pharma
MSD has lifted the veil on new Phase 3 for its blockbuster immunotherapy Keytruda, showing that the anti-PD-1 therapy met …
Sanofi and Regeneron’s Dupixent combo impresses in paediatric atopic dermatitis
April 3, 2020Medical Communications, Research and Development Dupixent, Sanofi, atopic dermatitis, pharma
Sanofi and Regeneron have unveiled new Phase 3 data for their IL-4 and IL-13 inhibitor Dupixent (dupilumab), showing strong results …
US approval for haemophilia drug derived from genetically engineered rabbit’s milk
April 2, 2020Sales and Marketing FDA, US, haemophilia, pharma
The FDA has announced the approval of Sevenfact, a haemophilia therapy the active ingredient from which is expressed in genetically …
Latest content
Five Facts about cardiovascular disease
